- Medication indicated for the treatment of AML and small lymphocytic lymphoma
- Inhibits Bcl-2
- Adverse effects include neutropenia, diarrhea, nausea, anemia, and fatigue
- Relatively high risk of invasive fungal infection when combined with azacitadine for treatment of AML
